JP7824667B2 - ピリミドピリミジノン化合物及びそれを含む薬剤学的組成物 - Google Patents
ピリミドピリミジノン化合物及びそれを含む薬剤学的組成物Info
- Publication number
- JP7824667B2 JP7824667B2 JP2023515773A JP2023515773A JP7824667B2 JP 7824667 B2 JP7824667 B2 JP 7824667B2 JP 2023515773 A JP2023515773 A JP 2023515773A JP 2023515773 A JP2023515773 A JP 2023515773A JP 7824667 B2 JP7824667 B2 JP 7824667B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidin
- benzamide
- compound
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200119100 | 2020-09-16 | ||
| KR10-2020-0119100 | 2020-09-16 | ||
| PCT/KR2021/012616 WO2022060094A1 (ko) | 2020-09-16 | 2021-09-15 | 피리미도 피리미디논 화합물 및 그를 포함하는 약제학적 조성물 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023541052A JP2023541052A (ja) | 2023-09-27 |
| JP2023541052A5 JP2023541052A5 (https=) | 2024-09-24 |
| JPWO2022060094A5 JPWO2022060094A5 (https=) | 2024-09-24 |
| JP7824667B2 true JP7824667B2 (ja) | 2026-03-05 |
Family
ID=80777269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515773A Active JP7824667B2 (ja) | 2020-09-16 | 2021-09-15 | ピリミドピリミジノン化合物及びそれを含む薬剤学的組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12590098B2 (https=) |
| EP (1) | EP4215533B1 (https=) |
| JP (1) | JP7824667B2 (https=) |
| KR (1) | KR102673031B1 (https=) |
| CN (1) | CN116137815B (https=) |
| AU (1) | AU2021344164A1 (https=) |
| BR (1) | BR112023004179A2 (https=) |
| CA (1) | CA3190461A1 (https=) |
| IL (1) | IL300920A (https=) |
| MX (1) | MX2023003087A (https=) |
| WO (1) | WO2022060094A1 (https=) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007500725A (ja) | 2003-07-29 | 2007-01-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | プロテインキナーゼ阻害剤としての化合物および組成物 |
| JP2008510690A (ja) | 2004-08-31 | 2008-04-10 | エフ．ホフマン−ラ ロシュ アーゲー | ３−フェニル−ジヒドロピリミド［４，５−ｄ］ピリミジノンのアミド誘導体、これらの製造、及び医薬品としての使用 |
| JP2008545442A (ja) | 2005-06-10 | 2008-12-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 胚幹細胞の多分化能を維持する化合物 |
| US20100093766A1 (en) | 2005-03-25 | 2010-04-15 | Callahan James F | Novel compounds |
| JP2019527682A (ja) | 2016-07-05 | 2019-10-03 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | 二環式尿素キナーゼインヒビターおよびそれらの使用 |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| JP2023511096A (ja) | 2020-01-15 | 2023-03-16 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | タンパク質キナ－ゼ阻害活性を有する７－アミノ－３，４－ジヒドロピリミドピリミジン－２－オン誘導体およびこれを含む治療用薬学組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2455382B1 (en) | 2005-12-13 | 2016-10-26 | Incyte Holdings Corporation | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| GB201315072D0 (en) | 2013-08-23 | 2013-10-02 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereoffor the treatment of proliferative disorders |
-
2021
- 2021-09-15 MX MX2023003087A patent/MX2023003087A/es unknown
- 2021-09-15 CA CA3190461A patent/CA3190461A1/en active Pending
- 2021-09-15 JP JP2023515773A patent/JP7824667B2/ja active Active
- 2021-09-15 EP EP21869716.7A patent/EP4215533B1/en active Active
- 2021-09-15 IL IL300920A patent/IL300920A/en unknown
- 2021-09-15 KR KR1020210123331A patent/KR102673031B1/ko active Active
- 2021-09-15 CN CN202180063334.1A patent/CN116137815B/zh active Active
- 2021-09-15 WO PCT/KR2021/012616 patent/WO2022060094A1/ko not_active Ceased
- 2021-09-15 US US18/245,395 patent/US12590098B2/en active Active
- 2021-09-15 BR BR112023004179A patent/BR112023004179A2/pt unknown
- 2021-09-15 AU AU2021344164A patent/AU2021344164A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007500725A (ja) | 2003-07-29 | 2007-01-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | プロテインキナーゼ阻害剤としての化合物および組成物 |
| JP2008510690A (ja) | 2004-08-31 | 2008-04-10 | エフ．ホフマン−ラ ロシュ アーゲー | ３−フェニル−ジヒドロピリミド［４，５−ｄ］ピリミジノンのアミド誘導体、これらの製造、及び医薬品としての使用 |
| US20100093766A1 (en) | 2005-03-25 | 2010-04-15 | Callahan James F | Novel compounds |
| JP2008545442A (ja) | 2005-06-10 | 2008-12-18 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 胚幹細胞の多分化能を維持する化合物 |
| JP2019527682A (ja) | 2016-07-05 | 2019-10-03 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | 二環式尿素キナーゼインヒビターおよびそれらの使用 |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| JP2023511096A (ja) | 2020-01-15 | 2023-03-16 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | タンパク質キナ－ゼ阻害活性を有する７－アミノ－３，４－ジヒドロピリミドピリミジン－２－オン誘導体およびこれを含む治療用薬学組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4215533B1 (en) | 2026-02-11 |
| CN116137815A (zh) | 2023-05-19 |
| BR112023004179A2 (pt) | 2023-04-11 |
| US20230348474A1 (en) | 2023-11-02 |
| KR20220036895A (ko) | 2022-03-23 |
| EP4215533A4 (en) | 2024-12-18 |
| IL300920A (en) | 2023-04-01 |
| WO2022060094A1 (ko) | 2022-03-24 |
| JP2023541052A (ja) | 2023-09-27 |
| CN116137815B (zh) | 2025-08-19 |
| KR102673031B1 (ko) | 2024-06-07 |
| CA3190461A1 (en) | 2022-03-24 |
| MX2023003087A (es) | 2023-04-14 |
| AU2021344164A9 (en) | 2024-03-21 |
| AU2021344164A1 (en) | 2023-05-04 |
| US12590098B2 (en) | 2026-03-31 |
| EP4215533A1 (en) | 2023-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9024021B2 (en) | Diarylacetylene hydrazide containing tyrosine kinase inhibitors | |
| TWI385165B (zh) | 經二取代之呔猬狀途徑拮抗劑 | |
| CA2764027C (en) | Quinoline or isoquinoline compounds useful for treating premature aging and in particular progeria | |
| US10710996B2 (en) | Pyrido-azaheterecydic compound and preparation method and use thereof | |
| US8586565B2 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
| US9617257B2 (en) | Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors | |
| US8461179B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| EP3653620B1 (en) | New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2) | |
| US20150152088A1 (en) | Alkynyl heteroaromatic compound and use thereof | |
| US12312337B2 (en) | Compounds and methods for treating cancer | |
| US20180271846A1 (en) | Five-membered heterocyclic amides wnt pathway inhibitor | |
| US20210395242A1 (en) | Heterocyclic compounds as ahr modulators | |
| US20200061065A1 (en) | Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof | |
| US11548900B2 (en) | Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof | |
| CN115160309B (zh) | Krasg12c突变蛋白杂环类抑制剂的制备及其应用 | |
| JP7824667B2 (ja) | ピリミドピリミジノン化合物及びそれを含む薬剤学的組成物 | |
| KR20180105926A (ko) | 퀴나졸린, 퀴놀린 유도체 및 egfr 키나제 억제제로서의 용도 | |
| US11407760B2 (en) | Dioxinoquinoline compounds, preparation method and uses thereof | |
| TWI546304B (zh) | Protein tyrosine kinase inhibitors and their use | |
| TW202432118A (zh) | 蛋白質酪胺酸磷酸酶抑制劑、其組合物及使用方法 | |
| JP2021155336A (ja) | 新規ｐｄｅ４阻害剤 | |
| US20250235453A1 (en) | Triazolopyridazine compounds useful as rac1 inhibitors | |
| WO2022166468A1 (zh) | Bruton's酪氨酸激酶抑制剂及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240912 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240912 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250729 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251028 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260120 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260213 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7824667 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |